Specify a stock or a cryptocurrency in the search bar to get a summary
Optomed PLC
OPTOMEDOptomed Oyj, together with its subsidiaries, manufactures and sells handheld fundus cameras in Finland and internationally. It operates in two segments, Devices and Software. The company develops, manufactures, and sells fundus cameras for ophthalmologists, pediatricians, endocrinologists, neurologists, and primary care professionals; and provides professional IT consulting services for government institutions. It offers camera products under the Optomed Smartscope Pro, Optomed Aurora, and Optomed Polaris brand names, as well as OEM cameras under the Pictor Plus and Pictor Prestige (Volk), Visuscout 100 (Zeiss), Fundus Module 300 (The Haag-Streit), and Signal (Topcon) brand names. The company provides Avenue Eye Screen, a workflow management software for screening and monitoring of eye diseases; Avenue Archive, an application software for displaying, archiving, and transmitting healthcare information; Avenue Telemedicine, a remote analysis solution; Avenue AI, a diabetic retinopathy screening service; Avenue Sync, a software for integrating fundus camera to the hospital image archive and worklist server; Avenue Flow, an eyecare management software; and Avenue SaaS, a software-as-a-service platform. In addition, it offers Cancer Screen, a screening process management software; Optomed RIS, a software solution for healthcare imaging units; Sectra PACS, a modular system for healthcare providers; Optomed Service Portal, a support function for healthcare units; and Pathology PACS, which allows digital pathology images to be reviewed and shared. It sells its products through OEMs, distributors, and direct sales to hospitals, eye clinics, and optician chains and stores. Optomed Oyj was incorporated in 2004 and is headquartered in Oulu, Finland. Address: Yrttipellontie 1, Oulu, Finland, 90230
Analytics
WallStreet Target Price
5.32 EURP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures OPTOMED
Dividend Analytics OPTOMED
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History OPTOMED
Stock Valuation OPTOMED
Financials OPTOMED
Results | 2019 | Dynamics |